HSD12 Reasons for Choice and Areas for Improvements of Advanced Therapies (Biologics and Janus Kinase Inhibitors) for Patients With Ulcerative Colitis in the United Kingdom
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1356
https://www.valueinhealthjournal.com/article/S1098-3015(22)03561-6/fulltext
Title :
HSD12 Reasons for Choice and Areas for Improvements of Advanced Therapies (Biologics and Janus Kinase Inhibitors) for Patients With Ulcerative Colitis in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03561-6&doi=10.1016/j.jval.2022.09.1356
First page :
Section Title :
Open access? :
No
Section Order :
10905